Ocular in Situ Gels: Development, Evaluation and Advancements

References

[1] Kamel A.; In vitro and in vivo evaluation of Pluronic F127- based ocular delivery system for timolol maleate; International Journal of Pharmaceutics; 2002; 24 (1): 47–55.

[2] Varshosaz J, Tabbakhian M, Salmani Z; Designing of a Thermo sensitive Chitosan/Poloxamer In Situ Gel for Ocular Delivery of Ciprofloxacin; The Open Drug Delivery Journal; 2008; 2: 61-70.

[3] Saini; In situ gels- a new trends in ophthalmic drug delivery systems, International Journal recent Advanced Pharmaceutical Research; 2015; 5 (3): 285-289.

[4] Peppas NA, Langer R; New challenges in biomaterials; Science; 1994; 263(154): 1715-1720.

[5] Swapnil S; A Review on polymers used in novel in situ gel formulation for ocular drug delivery and their evaluation; Journal of biological and scientific opinion; 2003; 1(2):132-137.

[6] Patel N, Rajesh K; ophthalmic in situ gel; Pharmagene; 2014; 1(4): 29-33.

[7] Pandya TP, Modasiya MK., Patel VM; Opthalmic in-situ gelling system; International Journal of Pharmacy & Life sciences ;) 2011; 2(5): 730-738.

[8] Jitendra PK, Sharma A, Banik, Dixit S; A new trend ocular drug delivery system. International. Journal. Of Pharmaceutical. Sciences; 2011; 2(3): 720-744.

[9] Nagyova B, Tiffany JM; Components responsible for the surface tension of human tears; Current Eye Research; 1999; 19(1): 4-11.

[10] Jain R, Shastri P; Study of ocular drug delivery system using drug loaded liposomes; International. Journal. Of Pharmaceutical. Science Investigation; 2011; 1(1): 234-244.

[11] Abdelbary G; Niosome-Encapsulated Gentamicin for Ophthalmic Controlled Delivery; AAPS Pharm Sci Tech; 2008; 9(3): 740–747.

[12] Taban M, Lowder C, Kaiser Y; Outcome of Fluocinolone acetonide implant reimplantation for chronic non-infectious posterior uveitis; Retina; 2008; 2 (8): 1280–1288.

[13] Vandamme TF, Brobeck L; Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropic amide; Journal of Control Release; 2005; 102: 23- 38.

[14] Vandamme TF; Micro emulsions as ocular drug delivery systems: recent development and future challenges; Progress in Retinal and Eye Research; 2002; 21: 15–34.

[15] Pignatello R; Flurbiprofen-loaded acrylate polymer nano suspensions for ophthalmic application; Biomaterials; 2002; 23: 3247-3255.

[16] Wen-Di Ma, Hui Xu, Chao Wang, Shu-Fang Nie, Wei-San Pan; Pluronic F127-gpoly (acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system, International Journal of Pharmaceutics; 2008; 350: 247-256.

[17] Gariepy ER, Leroux GC; In situ-forming hydrogels-review of temperature sensitive systems; European Journal of Pharmaceutics and Bio pharmaceutics; 2004; 58: 409–426.

[18] Masteikova R, Chalupova Z, Sklubalova Z; Stimuli-sensitive hydrogels in controlled and sustained drug delivery; Medicina; 2003; 39:19-24.

[19] Tomme SRV, Storm G, Hennink EW; In situ gelling hydrogels for pharmaceutical and biomedical application; International Journal of Pharmaceutics; 2008; 355: 1–18.

[20] Ravindra Reddy K, Ravi Shankar Yadav M, Sabitha Reddy P; Preparation and evaluation of Aceclofenac ophthalmic In situ gels; Journal of Chemical, Biological and Physical Sciences. 2011; 1(2): 289-298.

[21] Katariya dhirajkumar champalal, Poddar Sushilkumar S; Current status of ophthalmic insitu forming hydrogel. International Journal of Pharma and Bio Sciences. 2012; 3(3): 372-388.

@article{1718196,
      author = {Nidhi Singh, Madhuri Dubey},
      title = {Ocular in Situ Gels: Development, Evaluation and Advancements},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {9},
      number = {11},
      pages = {3300-3307},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1718196.pdf},
      abstract = {The ocular route of drug administration is regarded as one of the most challenging yet essential pathways for effective therapy, primarily due to the unique anatomical and physiological barriers of the eye. Conventional ophthalmic dosage forms such as eye drops and ointments suffer from rapid precorneal elimination caused by blinking, tear turnover, nasolacrimal drainage, and limited corneal permeability. As a result, these formulations exhibit short residence time on the ocular surface, leading to poor bioavailability and the need for frequent administration, which ultimately reduces patient compliance. To overcome these limitations, significant research efforts have been directed toward the development of novel ophthalmic drug delivery systems capable of prolonging drug residence time and improving therapeutic efficacy. Among these approaches, in situ gel-based delivery systems have gained considerable attention. In situ gels are administered as low-viscosity liquids that undergo phase transition into a gel upon exposure to ocular physiological conditions such as temperature, pH, or ionic strength. This transformation allows the formulation to remain in contact with the ocular surface for an extended period, thereby reducing drug loss and enhancing absorption. Recent advancements in ophthalmic drug delivery focus on integrating multiple formulation strategies to achieve sustained and controlled drug release. These systems not only increase the contact time of the formulation at the corneal surface but also slow down drug elimination, resulting in improved bioavailability and reduced dosing frequency. In situ gel systems have demonstrated promising potential in delivering a wide range of ophthalmic drugs, including antibiotics, anti-inflammatory agents, anti-glaucoma drugs, and antifungals. This review comprehensively discusses ocular in situ gel drug delivery systems, highlighting their formulation approaches, mechanisms of gelation, evaluation parameters, and therapeutic applications. Emphasis is placed on their advantages over conventional ophthalmic formulations and their role in enhancing ocular drug bioavailability and patient compliance},
      keywords = {Insitu Gel, Novel Ocular Drug Delivery System, Ph‐Triggered Insitu System, Ion‐Activated Insitu System, Temperature Evident Insitu System, Sol to Gel.},
      month = {May},
      doi = {https://doi.org/10.64388/IREV9I11-1718196}
  }